Delivery Order SPE2DB20D2104-SPE2DB24FR04S
- Not listed
- This federal contract award, valued at $2,785.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,605.17 firm fixed-price delivery order is for DETROL LA 4 MG CAPSULE 500S, a pharmaceutical product. The contract has a completion date of September 26, 2023 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,655.44 firm-fixed-price delivery order is for DETROL LA 4 MG CAPSULE 500S, with a performance period ending on May 8, 2023. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,677.82 firm fixed-price contract is for the supply of Detrol LA 4 mg capsules. The contract has a period of performance ending on March 31, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $1,084.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DETROL LA 4 MG CAPSULE 90S, a prescription medication, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, is a delivery order valued at $6,995.48 for the supply of Detrol LA 4 mg capsules. The award was made by the Defense Logistics Agency (DLA), a civilian defense agency that serves as a critical supplier of medical and pharmaceutical products to federal agencies. The contract is a firm fixed-price delivery order with a completion date of September 15, 2023. It is not...
- This federal contract award, valued at $38,279.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DETROL LA 4 MG CAPSULE 90S, with an ultimate completion date of September 20, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,175.31, is for the delivery of DETROL LA 4 MG CAPSULE 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 26, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, valued at $62,151.77. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of DETROL LA 4 MG CAPSULE 500S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,010.00, is for the delivery of 4562600608 DETROL LA 4 MG CAPSULE 500S. This is a firm fixed-price delivery order contract with an ultimate completion date of October 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR04SDelivery Order
This federal contract award, valued at $50,815.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for the delivery of 500 units of the medication DETROL LA 4 MG CAPSULE, with a performance period ending on November 6, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside requirements indicated. AmerisourceBergen's extensive experience as a vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, positions the company as a key supplier of essential pharmaceutical and medical commodities to support the medical needs of service members, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.8k | 11/3/23 |